Moreover, the substance reduced the survival and cell proliferation of MCF-7 breast cancer cells that were resistant to tamoxifen (antagonist of estrogen receptor) as well as confined estrogen receptor alpha to the perinuclear region of the cancerous cell [178]. This evidence concerns the gene ESR1 and breast cancer.